Lastly we found, using the online KM- Plotter database [37], that ER+ BC patients express higher levels of CETP and have a significantly lower probability of long-term survival (P-value < 0.0032) as compared to ER- patients (Figure 5F). This evidence concerns the gene ESR1 and breast cancer.